Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitazoxanide for Severe Acute Respiratory Illness
NCT02057757Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Feb 2014
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nitazoxanide in acute respiratory illness (ARI), sponsored by National Institute of Allergy and Infectious Diseases. Started Feb 2014; status: completed.
02
Drugs
nitazoxanide
03
Conditions
acute respiratory illness (ARI)
Beyond the preview
Go deeper on NCT02057757.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02057757.